Molecular mechanism of size control in development and human diseases.
about
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.An estimation of the number of cells in the human body.Adaptation of the length scale and amplitude of the Bicoid gradient profile to achieve robust patterning in abnormally large Drosophila melanogaster embryos.ERK7 is a negative regulator of protein secretion in response to amino-acid starvation by modulating Sec16 membrane associationFundamental origins and limits for scaling a maternal morphogen gradient.Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2.Discovery of a novel target for cancer: PRR14Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor.SNX27 links DGKζ to the control of transcriptional and metabolic programs in T lymphocytes.Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma.A Microarray Study of Carpet-Shell Clam (Ruditapes decussatus) Shows Common and Organ-Specific Growth-Related Gene Expression Differences in Gills and Digestive Gland.Influence of cell size on cellular uptake of gold nanoparticles.Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.Electromechanics and Volume Dynamics in Nonexcitable Tissue CellsA LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.
P2860
Q30008849-370D0F7D-ACA1-4868-96A3-97EAECA40DF5Q34037445-DBDF85C0-5A37-4B4E-838F-19C5ED25BCA1Q34388404-A92DBA54-66C8-4EEC-9D17-1960249605FDQ35214896-6864FAA9-EDC7-47A8-AF8A-5D75506A154DQ35222308-7A6D61A6-21E0-46D5-9D6D-AF8E340AD819Q35623178-AD4D0546-4AB4-4F3C-9370-64F6CBE46953Q37603511-B512B0CD-266A-43AC-84F2-CCFBE2F3368AQ38872721-2EF99DA0-C504-4C88-9423-8AC229BA15E8Q39101629-7914DAF2-FD5B-4701-BFFB-77839A1D4E98Q47095791-0944B269-8C82-4C9E-BAF1-85B4F22592A2Q47099754-29F796D1-4967-4212-AFCC-531F2E00CC69Q47109292-A02C8D8D-950E-49CE-84C0-DEAD3416259FQ47310068-40975D5E-6F90-4EDF-B7B5-815B4297A92CQ51611915-6F9C4FE8-BDBB-44A5-AB7F-7F45DFAA348CQ53058120-5F9600FB-842D-464C-9200-CAB938D6D331Q54982188-3231345D-6344-499E-B18D-DFD1FA58F6B6
P2860
Molecular mechanism of size control in development and human diseases.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular mechanism of size control in development and human diseases.
@ast
Molecular mechanism of size control in development and human diseases.
@en
type
label
Molecular mechanism of size control in development and human diseases.
@ast
Molecular mechanism of size control in development and human diseases.
@en
prefLabel
Molecular mechanism of size control in development and human diseases.
@ast
Molecular mechanism of size control in development and human diseases.
@en
P2860
P356
P1433
P1476
Molecular mechanism of size control in development and human diseases.
@en
P2093
Xiaolong Yang
P2860
P2888
P304
P356
10.1038/CR.2011.63
P577
2011-04-12T00:00:00Z